Lenalidomide After Failure of Hypomethylating Agents in Myelodysplastic Syndrome

NCT01673308 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Myelodysplastic Syndrome

Interventions

DRUG: Lenalidomide

Sponsor

Ulsan University Hospital

Collaborators

[object Object]